Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

BIZARRE: Marketbeat - What They Never Told You

Amneal Pharmaceuticals Bets on Biosimilars, Patches to Power Next Growth Phase

Amneal Pharmaceuticals (NASDAQ:AMRX) Co-Founder, President and Co-Chief Executive Officer Chirag Patel said the company is entering a stronger growth phase, driven by momentum in its existing generics portfolio, a newly expanded biosimilars platform and specialty product launches. Speaking at a Gol

MarketBeat

The Bank of Mom and Dad Is Booming—3 Stocks to Watch

Rising financial dependence on parents is creating investment opportunities; here are three stocks that could benefit from this growing trend

MarketBeat

Corning Is Paving AI's Future With Glass

The recent Amazon infrastructure pact proves that hyperscalers are abandoning legacy copper cables in favor of advanced optical fiber for high-speed computing.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Why's Amazon Suddenly Lagging the S&P 500, and Is It a Warning?

Amazon's pullback is about capex fears, not business deterioration, and with AWS accelerating and analysts staying bullish, this could be a great entry point.

MarketBeat

Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer

Bitcoin has fallen below $60,000 amid record ETF outflows and institutional selling, making MSTR, BLSH, and BITO the stocks most exposed to a crypto downturn.

MarketBeat

Alnylam Pharmaceuticals Unveils 2030 Targets, Betting on AMVUTTRA and Pipeline Readouts

Alnylam Pharmaceuticals (NASDAQ:ALNY) executives outlined the company’s 2030 financial targets, TTR franchise strategy and near-term pipeline priorities during a Goldman Sachs event hosted by analyst Salveen Richter. Jeff Poulton, Alnylam’s chief financial officer, said the company’s “Alnylam 2030”

MarketBeat

Uranium Energy Q3 Earnings Call Highlights

Uranium Energy (NYSEAMERICAN:UEC) said on its latest earnings call that it advanced several parts of its U.S. uranium production platform during the quarter, including the start of production at Burke Hollow in South Texas and continued development at Christensen Ranch in Wyoming. Founder and Chief

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Oil-Dri Corporation Of America Q3 Earnings Call Highlights

Oil-Dri Corporation Of America (NYSE:ODC) reported stronger fiscal third-quarter sales and operating income, while management cautioned that higher costs and an ongoing capital investment cycle are continuing to pressure margins. On the company’s Q3 fiscal 2026 earnings webcast, Chief Financial Off

MarketBeat

Academy Sports and Outdoors Q1 Earnings Call Highlights

Academy Sports and Outdoors (NASDAQ:ASO) reported a return to comparable sales growth in its fiscal first quarter, with management pointing to gains across all major merchandise divisions, strong e-commerce growth and momentum from newer stores. The sporting goods retailer said first-quarter net sa

MarketBeat

The J.M. Smucker Company’s Dividend: Too Sweet to Ignore?

J.M. Smucker Compay is in the midst of a business turnaround that will deliver an attractive total return for income investors over time.

MarketBeat

From Crypto to AI: Insiders Are Trading These 3 Stocks

See the beaten-down and surging stocks that insiders are trading, from one of the biggest names in crypto to an NVIDIA-linked chip company.

MarketBeat

The Case for Intel Over Pure-Play Quantum Firms

Intel, IBM, and other legacy tech giants are doubling down on quantum computing, putting pure-play firms like D-Wave and Rigetti in a difficult position.

MarketBeat

United Natural Foods Q3 Earnings Call Highlights

United Natural Foods (NYSE:UNFI) reported stronger third-quarter fiscal 2026 profitability and cash flow despite lower sales, as management said network optimization, productivity initiatives and supply chain investments continued to reshape the business. On the company’s earnings call, CEO Sandy D

MarketBeat

Amgen Eyes 2026 ‘Springboard’ as Growth Drugs Offset Patent Pressure

Amgen (NASDAQ:AMGN) executives said the company’s first-quarter performance supports its view that 2026 can serve as a “springboard year,” with growth products helping offset increased competition for the denosumab franchise and other losses of exclusivity. Speaking at a Goldman Sachs event, Peter

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

SailPoint Q1 Earnings Call Highlights

SailPoint (NASDAQ:SAIL) reported a stronger-than-expected start to fiscal 2027, with management pointing to continued SaaS migration activity, larger customer commitments and growing demand for identity security tied to artificial intelligence agents and other non-human identities. On the company’s

MarketBeat

Titan Machinery Q1 Earnings Call Highlights

Titan Machinery (NASDAQ:TITN) reported fiscal first-quarter results that management said were slightly ahead of expectations, helped by earlier-than-anticipated equipment margin improvement, but the company reaffirmed its full-year outlook as demand remains pressured across key customer groups. Pre

MarketBeat

Lands' End Q1 Earnings Call Highlights

Lands' End (NASDAQ:LE) reported lower first-quarter revenue as a distribution center systems rollout delayed shipments, but executives said underlying demand improved and described the recently completed joint venture with WHP Global as a major strategic reset for the apparel retailer. Chief Execut

MarketBeat

Molten Ventures H2 Earnings Call Highlights

Molten Ventures (LON:GROW) said portfolio fair value growth accelerated during the year, while management pointed to defense, space, artificial intelligence and European technology sovereignty as major structural themes shaping its investment strategy. Chief Executive Ben Wilkinson told investors t

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

EHang Q1 Earnings Call Highlights

EHang (NASDAQ:EH) said it remains focused on moving from aircraft certification to commercial operations after reporting first-quarter 2026 revenue that was roughly flat year over year but sharply lower than the prior quarter due to delivery timing and seasonal factors. Founder, Chairman and Chief

MarketBeat

Apple's Siri AI Was Finally Announced, So Why Is the Stock Tanking?

Apple's Siri AI selloff looks more like impatience than insight, and with analysts firmly bullish this dip could end up being an opportunity.

MarketBeat

Tanker Dividends Are Surging, But Income Investors Need to Watch the Cycle

Frontline, Euroseas, and Nordic American Tankers raised dividends in 2026, with Frontline boosting its payout 50% after reporting its highest quarterly profit since 2004.

MarketBeat

Has Temu-Owner PDD's Story Changed After Double Miss?

Temu owner PDD keeps sinking. The company is prioritizing long-term competitiveness over short-term results, creating potential for an extended recovery.

MarketBeat

These 3 Stocks Lowered Their Share Counts Drastically in Q1

Pinterest, Southwest Airlines, and United Therapeutics each executed significant share repurchases in Q1 2026, reducing their outstanding share counts by 16%, 5%, and 3.2%, respectively.

MarketBeat

J. M. Smucker Q4 Earnings Call Highlights

J. M. Smucker (NYSE:SJM) executives said the company is entering fiscal 2027 with momentum across key brands, while cautioning that commodity costs, tariffs and consumer behavior remain important variables in its outlook. During the company’s fiscal fourth-quarter earnings question-and-answer sessi

MarketBeat

Annexon Eyes ‘Win Season’ With Q4 Vision Trial Data, GBS Filings Ahead

Annexon (NASDAQ:ANNX) executives used a Goldman Sachs Healthcare Conference session to outline the company’s upcoming clinical and regulatory catalysts, led by pivotal Phase III data expected in the fourth quarter for vonaprument in geographic atrophy, a form of advanced dry age-related macular dege

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.